![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Oncogenes, Tumor Suppressor Genes and Apoptosis-Inducing Genes Utilized in Cancer Gene Therapy
Oncogenes, tumor suppressor genes, and apoptosis-inducing genes play critical roles in cell proliferation, differentiation, and death. Their expressions are frequently altered in cancer cells by gene mutation,...
-
Chapter
Adenovector-Mediated Cancer Gene Therapy
Early-region (E1)-deleted, replication-defective adenovectors have been widely used in preclinical and clinical studies of cancer gene therapy. Recently, the use of conditional replicating or oncolytic adenove...
-
Chapter
Gene Therapy Targeting Receptor-Mediated Cell Death to Cancers
Research has demonstrated that delivery of genes encoding tumor necrosis factor (TNF)-α, Fas ligand (FasL), and TNF-related apoptosis-inducing ligand (TRAIL) to tumors can elicit apoptosis in cancer cells and ...